MedTrace Logo

Efficacy of Biological Technique in Upper Canine Retraction and Levels of Discomfort

NCT03399422 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-02-05

No results posted yet for this study

Summary

Twenty patients need therapeutic extraction of the maxillary first premolars with subsequent retraction of the maxillary canines, will be divided randomly into two groups, and will randomly assigned to one side of the maxillary arch at the first premolar region , and the other side served as the control. canine retraction will be initiated after completion of the leveling and alignment phase via closed nickel-titanium coil springs applying 150 g of force per side , soldered transpalatal arch will be used as an anchor unit.

Pre- and post distalization dental casts will be evaluated to study rate of canine distalization, over a follow-up period until a Class I canine relationship will be achieved. The levels of Pain and discomfort will be monitored using a questionnaire with a VAS scale administered three times during the first day after prf injection.

Conditions

  • Malocclusion, Angle Class II, Division 1

Interventions

BIOLOGICAL

i-PRF

i-PRF (injectable platelet rich fibrin) assisted upper canine retraction

PROCEDURE

canine retraction

upper canine retraction will be performed in one side of patients with Class II Division 1 malocclusion patients requiring therapeutic extraction of the maxillary first premolars

Sponsors & Collaborators

  • Damascus University

    lead OTHER

Principal Investigators

  • Rania Haddad, PhD. · Department of Orthodontics, Faculty of Dentistry, Damascus University, Damascus, Syria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
15 Years
Max Age
27 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-20
Primary Completion
2018-08-01
Completion
2019-08-01

Countries

  • Syria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03399422 on ClinicalTrials.gov